10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7 | -30.0% | 175 | -1.7% | 0.01% | -37.5% |
| Q2 2023 | $10 | -44.4% | 178 | -43.5% | 0.01% | -50.0% |
| Q1 2023 | $18 | -25.0% | 315 | -50.2% | 0.02% | +60.0% |
| Q4 2022 | $24 | -99.5% | 632 | +241.6% | 0.01% | +150.0% |
| Q3 2022 | $5,000 | -37.5% | 185 | +2.8% | 0.00% | -33.3% |
| Q2 2022 | $8,000 | +33.3% | 180 | +127.8% | 0.01% | +50.0% |
| Q1 2022 | $6,000 | -81.2% | 79 | -63.6% | 0.00% | -91.1% |
| Q4 2021 | $32,000 | – | 217 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |